MedPath

Epidural Analgesia and Delivery of Second Twin

Completed
Conditions
Epidural
Analgesia
Labor Pain
Interventions
Drug: Bupivacaine-fentanyl
Registration Number
NCT04608006
Lead Sponsor
Abdelrady S Ibrahim, MD
Brief Summary

Over an 8-year period, 124 twin pregnancies at gestational age ≥32 weeks with both twins presenting as a vertex and eligible for vaginal delivery were reviewed. Excluded were patients with the following intrapartum factors which may affect mode of delivery of second twin: 1. Presentation of the 2nd twin: breech or other than vertex; 2. Monochorionic twins; 3. Induction of labour; 4. difference in foetal weight between twin B and twin A ≥25%. The chi-square statistic was used to compare differences in the incidence of retained second twin between the groups.

Detailed Description

The investigators conducted this prospective study in women with twins pregnancy planned for trial of vaginal delivery and gave birth between January 2014 and December 2019, in the Department of obstetrics and Gynaecology of the Sabah Maternity Hospital, Sabah Specialized Area, Kuwait. The Sabah Maternity Hospital is a tertiary care hospital for the country of Kuwait with approximately 12500 deliveries per year. The study protocol was approved by the Ethics Committee.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
124
Inclusion Criteria

.gestational age of 32 weeks, determined by an early ultrasound performed in the second trimester or certain last menstrual period; (2) both twins viable; (3) eligibility for vaginal delivery as defined by twin A being cephalic; and (4) no previous cesarean section.

Exclusion Criteria
  • underwent an elective or repeat cesarean section
  • presentation of twin B at delivery other than cephalic (breech, oblique or transverse presentation
  • induction of labour
  • the difference in foetal weight between twin B and twin A at delivery ≥25% .Neonates were excluded if one was stillborn or had major congenital malformations.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Vaginal DeliveryBupivacaine-fentanylDelivered both twins vaginally
C-Section DeliveryBupivacaine-fentanylDelivered both twins by Cesarean Section
Vaginal/C-Section DeliveryBupivacaine-fentanylDelivery first twin vaginally and second twin By C-Section.
Primary Outcome Measures
NameTimeMethod
Delivery of First twin24 hours

Vaginal or C-Section

Delivery of Second twin24 hours

C-Section or C-Section

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut university faculty of medicine

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath